Translational Development Acquisition Corp. Ordinary Shares (TDAC) stock price

Translational Development Acquisition Corp. Ordinary Shares (TDAC) is a Financial Services · Shell Companies company listed on NASDAQ. Price $10.88 (+0.18%), Market cap $0.23B, P/E ratio 38.00, 52-week low–high $10.19 ~ $10.69.

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Translational Development Acquisition Corp. Ordinary Shares are updated in real time on BlackAll Trade.

Translational Development Acquisition Corp. Ordinary Shares financial summary

Key ratios · profitability · growth

Frequently asked questions

What is the current Translational Development Acquisition Corp. Ordinary Shares (TDAC) stock price?

Translational Development Acquisition Corp. Ordinary Shares trades at $10.88 (+0.18%). Real-time quotes and charts are available on BlackAll Trade.

What is the Translational Development Acquisition Corp. Ordinary Shares (TDAC) market cap?

Translational Development Acquisition Corp. Ordinary Shares has a market cap of about $0.23B. Its P/E ratio is 38.00.

What does Translational Development Acquisition Corp. Ordinary Shares (TDAC) do?

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganizatio